Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.
Journal: Frontiers in oncology
Published: October 02, 2018
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: June 04, 2016
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.
Journal: Journal of clinical medicine
Published: May 02, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026